
Bayer AG
Bayer AG (BAYRY) Free Cash Flow & Analysis
Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.
BAYRY · free cash flow · updated Jun 8, 2026
Core FCF metrics
BAYRY · FCF · TTM · margin & CAGRFree cash flow was $2.00B for FY2025 (fiscal year ending 2025-12-31), down 56.4% year-over-year The FCF margin was 4.6%. Five-year CAGR stands at -4.2%.
Annual free cash flow history
Annual free cash flow data
FCF valuation metrics
BAYRY · P/FCF · FCF yield · FCF per shareBayer AG (BAYRY) trades at a FCF yield of 5.76% and a price-to-free-cash-flow ratio of 24.4x. FCF per share stands at $0.42, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.
Cash flow statement summary
BAYRY · cash flow statement · operating / investing / financingFor FY2025, Bayer AG generated $4.39B in operating cash flow and spent 2.39B in capital expenditures, yielding $2.00B in free cash flow.
For the complete Operating / Investing / Financing line-item breakdown:
View Full Cash Flow Statement →Free cash flow vs peers (Healthcare)
About Free Cash Flow & Methodology
Bayer AG (BAYRY) reported free cash flow of $2.00B for FY2025 (fiscal year ending 2025-12-31), down 56.4% year-over-year. The FCF margin was 4.6%.
Based on available data, Bayer AG has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $6.51B in FY2016. The 5-year CAGR stands at -4.2%.
Bayer AG's FCF yield is 5.76% and price-to-FCF ratio is 24.4x for FY2025, based on the latest available data.
Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.
Frequently asked questions
BAYRY free cash flow · 8 questionsBayer AG free cash flow was $2.00B for FY2025, down 56.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $1.63B.
▸ Source: FMP /cash-flow-statement · US GAAP · Bayer AG · Bayer AG SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026